Literature DB >> 34343834

miR-96-5p is the tumor suppressor in osteosarcoma via targeting SYK.

Taiping Wang1, Yong Xu2, Xin Liu2, Yong Zeng2, Lei Liu2.   

Abstract

BACKGROUND: Osteosarcoma is a multiple malignant tumor in adolescents. MicroRNAs (MiRNAs) have been found to express abnormally in OS tissues and are considered as potential targets for OS prognosis and treatment.
METHODS: MiR-96-5p and SYK expression in clinical samples, osteoblast and OS cell lines were detected. The changes of cell proliferation, apoptosis, adhesion and metastasis of OS cells were detected by CCK-8, BrdU, caspase-3 activity and transwell assay. Dual luciferase report analysis and RNA pull-down were used to confirm binding relation of miR-96-5p and SYK.
RESULTS: MiR-96-5p was increased in OS tissue and cells. Moreover, miR-96-5p inhibits proliferation, adhesion and migration of HOS and Saos-2 cells, and promotes cell apoptosis. SYK has been identified to be targeted by miR-96-5p. Overexpressed SYK inhibits the suppressive impact of miR-96-5 on OS cells.
CONCLUSION: MiR-96-5p may function as an effective target in OS treatment.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Adhesion; MiR-96-5p; Osteosarcoma; Proliferation; SYK

Year:  2021        PMID: 34343834     DOI: 10.1016/j.bbrc.2021.07.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  RNA sequencing reveals the circular RNA expression profiles of the infrapatellar fat pad/synovium unit.

Authors:  Tao Jiang; Yimin Lu; Zehua Chen; Xiaodong Lin; Jiayuan Zhang; Jiaxin Shan; Chao Lu; Chuanxi Zhao; Xuemeng Xu; Wengang Liu
Journal:  Ann Transl Med       Date:  2021-11

2.  Mass Spectrometry and Computer Simulation Predict the Interactions of AGPS and HNRNPK in Glioma.

Authors:  Wei Zhou; Ying Liu; Honglian Li; Zhaoyu Song; Ying Ma; Yu Zhu
Journal:  Biomed Res Int       Date:  2021-09-28       Impact factor: 3.411

3.  miR-96-5p Induces Orbital Fibroblasts Differentiation by Targeting Smad7 and Promotes the Development of Thyroid-Associated Ophthalmopathy.

Authors:  Jianshu Kang; Yunqin Li; Yue Zou; Zhijian Zhao; Linan Jiao; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-27       Impact factor: 2.629

4.  LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.

Authors:  Zhen Wang; Yanting Wei; Hao Zhu; Lingfeng Yu; Jie Zhu; Qixiu Han; Ziying Liu; Jianhao Huang; Yan Zhu; Gentao Fan; Qikai Tang; Ji Qian; Xi Chen; Guangxin Zhou
Journal:  BMC Cancer       Date:  2022-07-04       Impact factor: 4.638

5.  Effect of Long Noncoding RNA HULC on Proliferation, Migration, and Invasion of Osteosarcoma Cells.

Authors:  Ran Zhao; Xin Zhou; Wencan Zhang; Le Li
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.